title: A placebo double-blind pilot study of dextromethorphan for problematic behaviors in children with autism.
abstract: We used a mixed group/single-case, double-blind, placebo-controlled, ABAB design to examine the safety and efficacy of the glutamate antagonist dextromethorphan for the treatment of problematic behaviors and core symptoms in eight children diagnosed with autism. All participants had increased levels of irritability at baseline as measured by the Aberrant Behavior Checklist, and demonstrated a wide variety of problematic behaviors. Group analyses revealed that dextromethorphan was equivalent to placebo in the treatment of problem behaviors and core symptoms. Analyses at the single-subject level demonstrated that three of the eight participants who had a behavioral profile consistent with attention-deficit hyperactivity disorder responded positively to dextromethorphan. Future research that employs a larger, more homogeneous sample is necessary to replicate the findings from this study.
authors.affiliation: Groden Center, Providence, RI 02906, USA.
authors.forename: Cooper
authors.initials: C
authors.lastname: Woodard
authors.forename: June
authors.initials: J
authors.lastname: Groden
authors.forename: Matthew
authors.initials: M
authors.lastname: Goodwin
authors.forename: James
authors.initials: J
authors.lastname: Bodfish
mesh_terms: D000293:Adolescent; D000294:Adolescent Behavior / Q000187:drug effects / Q000523:psychology; D000701:Analgesics, Opioid / Q000009:adverse effects / Q000627:therapeutic use; D001289:Attention Deficit Disorder with Hyperactivity / Q000150:complications / Q000188:drug therapy / Q000523:psychology; D001321:Autistic Disorder / Q000150:complications* / Q000188:drug therapy* / Q000523:psychology; D002648:Child; D002653:Child Behavior Disorders / Q000150:complications* / Q000188:drug therapy* / Q000523:psychology; D003915:Dextromethorphan / Q000009:adverse effects / Q000627:therapeutic use*; D004311:Double-Blind Method; D018691:Excitatory Amino Acid Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007508:Irritable Mood / Q000187:drug effects; D008297:Male; D010865:Pilot Projects; D010919:Placebos; D016896:Treatment Outcome
chemical_list: D000701:Analgesics, Opioid; D018691:Excitatory Amino Acid Antagonists; D010919:Placebos; D003915:Dextromethorphan